1373. Activity of Ceftriaxone–Sulbactam–EDTA Against Multi-Drug-resistant A. baumannii, P. aeruginosa and Enterobacteriaceae Isolates (WHO Critical Priority Pathogens) Collected fr...

por Girotra, Ruchi, Pyasi, Anurag, Chaudhary, Manu, Patil, N S, Mir, Mohd Amin, Chaudhary, Saransh, Mandale, Pankaj
Publicado 2018

1984. Ceftriaxone-Sulbactam-EDTA vs. Meropenem: Analysis of Failed Patients With Assessment of MIC Increases and Changes in Genotypic Profile in PLEA (a Phase 3, Randomized, Double...

por Mir, Mohd Amin, Chaudhary, Saransh, Chaudhary, Manu, Pyasi, Anurag, Patil, N S, Girotra, Ruchi, Narang, Salil, Fatima, Nazish
Publicado 2018

1974. Ceftriaxone-Sulbactam-EDTA vs. Meropenem in PLEA (a Phase 3, Randomized, Double-Blind Trial): Outcomes by Baseline MIC in Adults With Complicated Urinary Tract Infections or...

por Mandale, Pankaj, Mir, Mohd Amin, Chaudhary, Saransh, Chaudhary, Manu, Sood, Rajeev, Patil, N S, Narang, Salil, Pyasi, Anurag, Shameem, Mohammad
Publicado 2018